The goal is to develop a new approach that could directly correct the genetic error responsible for the disease. The researchers will use a recent technology called Prime Editing, which acts somewhat like a spell checker for DNA. Its role is to replace an incorrect letter in the genetic code.
Subvention : $100 000
Durée : un an
Dr Jacques-P. Tremblay
Professeur
Département de médecine moléculaire
Faculté de médecine de l'Université Laval
Ville de Québec, Québec, Canada
Contact : jacques-p.tremblay@fmed.ulaval.ca
